Startseite The crystal structure of trans-carbonyl-(diphenylcyclohexyl-phosphine-κP)iodidomethyl-(2-oxopyridin-1(2H)-olato-κ2O,O′)rhodium(III), C25H28INO3PRh
Artikel Open Access

The crystal structure of trans-carbonyl-(diphenylcyclohexyl-phosphine-κP)iodidomethyl-(2-oxopyridin-1(2H)-olato-κ2O,O′)rhodium(III), C25H28INO3PRh

  • Mohammed A. Elmakki ORCID logo EMAIL logo , Orbett T. Alexander ORCID logo und Andreas Roodt
Veröffentlicht/Copyright: 5. Dezember 2019

Abstract

C25H28INO3PRh, monoclinic, P21/c (no. 14), a = 11.339(4) Å, b = 9.887(5) Å, c = 23.069(9) Å, β = 91.125(5)°, Z = 4, V = 2585.7(19) Å3, Rgt(F) = 0.0463, wRref(F2) = 0.1093, T = 293(2) K.

CCDC no.: 1958026

Table 1 contains crystallographic data and Table 2 contains the list of the atoms including atomic coordinates and displacement parameters.

Table 1:

Data collection and handling.

Crystal:Orange stout
Size:0.29 × 0.15 × 0.09 mm
Wavelength:Mo Kα radiation (0.71073 Å)
μ:1.94 mm−1
Diffractometer, scan mode:Bruker APEX-II, φ and ω
θmax, completeness:28.0°, 99%
N(hkl)measured, N(hkl)unique, Rint:42669, 6211, 0.060
Criterion for Iobs, N(hkl)gt:Iobs > 2 σ(Iobs), 4321
N(param)refined:299
Programs:SHELX [1], Bruker [2], Diamond [3], Olex2 [4]
Table 2:

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).

AtomxyzUiso*/Ueq
Rh10.39428(3)0.63865(4)0.66930(2)0.03485(11)
P10.24271(10)0.62125(12)0.60246(5)0.0307(3)
O10.3885(3)0.8453(3)0.67480(15)0.0437(8)
O20.5274(3)0.6740(4)0.73280(16)0.0510(9)
N10.4818(4)0.8902(4)0.70546(18)0.0421(10)
C10.5516(4)0.8015(5)0.7350(2)0.0361(10)
C20.6471(5)0.8537(7)0.7673(2)0.0514(14)
H20.69700.79480.78750.062*
C30.6682(6)0.9894(8)0.7696(3)0.0682(19)
H30.73181.02270.79130.082*
C40.5939(6)1.0776(7)0.7393(3)0.0649(17)
H40.60681.17040.74120.078*
C50.5022(5)1.0274(5)0.7070(3)0.0517(14)
H50.45331.08580.68600.062*
C60.2768(5)0.6207(6)0.7377(2)0.0479(13)
H6A0.21020.56720.72550.072*
H6B0.25040.70900.74900.072*
H6C0.31590.57780.77010.072*
C80.1078(4)0.7094(5)0.6209(2)0.0354(10)
C90.1097(4)0.8248(5)0.6558(2)0.0398(11)
H90.18120.85680.67070.048*
C100.0071(5)0.8915(5)0.6681(2)0.0479(13)
H100.00920.96690.69230.057*
C11−0.0999(5)0.8471(6)0.6448(3)0.0577(15)
H11−0.16950.89240.65310.069*
C12−0.1018(5)0.7348(7)0.6089(3)0.0593(16)
H12−0.17290.70530.59250.071*
C130.0002(4)0.6668(6)0.5974(2)0.0480(13)
H13−0.00250.59100.57360.058*
C140.1986(4)0.4456(5)0.5930(2)0.0365(11)
C150.1191(5)0.3853(5)0.6291(2)0.0441(12)
H150.08250.43700.65720.053*
C160.0924(5)0.2495(6)0.6244(3)0.0542(14)
H160.03890.21040.64940.065*
C170.1443(7)0.1731(6)0.5833(3)0.0705(19)
H170.12450.08220.57950.085*
C180.2274(7)0.2301(6)0.5466(3)0.074(2)
H180.26420.17740.51890.089*
C190.2537(6)0.3653(6)0.5520(2)0.0563(15)
H190.30930.40370.52790.068*
C200.2788(4)0.6858(5)0.5295(2)0.0392(11)
H200.34920.63700.51710.047*
C210.1818(5)0.6591(7)0.4836(2)0.0571(15)
H21A0.16350.56330.48230.069*
H21B0.11070.70780.49350.069*
C220.2250(6)0.7064(9)0.4244(3)0.078(2)
H22A0.29180.65150.41330.094*
H22B0.16260.69360.39560.094*
C230.2612(7)0.8536(8)0.4255(3)0.086(2)
H23A0.29260.87800.38810.103*
H23B0.19220.90930.43200.103*
C240.3518(7)0.8817(7)0.4718(3)0.079(2)
H24A0.36800.97790.47300.095*
H24B0.42440.83540.46250.095*
C250.3110(6)0.8352(5)0.5315(2)0.0546(15)
H25A0.37360.84980.56010.066*
H25B0.24300.88780.54280.066*
I1a0.57361(4)0.64371(7)0.59102(2)0.06474(18)
O3a0.4217(7)0.3319(4)0.6760(3)0.0794(17)
C7a0.4127(10)0.4432(3)0.6698(4)0.0794(17)
I1Ab0.4667(2)0.3832(2)0.66140(12)0.0615(6)
O3Ab0.5711(18)0.688(3)0.5692(9)0.0794(17)
C7Ab0.503(2)0.666(3)0.6032(10)0.0794(17)
  1. aOccupancy: 0.8, bOccupancy: 0.2.

Source of material

[Rh(hopo)(CO)(PPh2Cy)] (hopo = 2-oxopyridin-1(2H)-olate) was synthesized according to the method described previously [5]. Rhodium(III) alkyl oxidative addition product [Rh(hopo)(CO)(CH3)(I)(PPh2Cy)] was prepared as follows: (0.100 g, 0.154 mmol) was dissolved in acetone (2 cm3) wherafter iodomethane (0.2186 g, 1.541 mmol) was added with stirring. The solution was stored at 25 °C for two days and yielded orange crystals (yield 68%).

IR: νCO 2056 cm−1. 31P NMR (162 MHz, CDCl3) δ [ppm] 40.96 (d, 1J(RhP)A = 123.8 Hz), 37.56 (d, 1J(RhP)B = 116.3 Hz); where A = major isomer, B = minor isomer.

Experimental details

All H-atoms were positioned on geometrically idealized positions and refined using the riding model with fixed C—H distances for aromatic C—H of 0.93 Å (C—H) [Uiso (H) = 1.2 Ueq], for methyl C—H of 0.96 Å (C—H) [Uiso(H) = 1.5 Ueq], for methylene C—H of 0.97 Å (C—H) [Uiso (H) = 1.5 Ueq] and for methine C—H of 0.98 Å (C—H) [Uiso (H) = 1.5 Ueq]. The graphics were obtained using the DIAMOND [3] program with 50% probability ellipsoids. The highest residual peak is located 0.77 Å from Rh and the deepest hole is situated 0.71 Å from Rh. The I1 and C7-O3 (carbonyl group) atoms are disordered in an approximate 80% ratio with the higher value attributed to the I1 trans methyl and the 20% isomer and hydrogen atoms in the figure are omitted for clarity.

Comment

The iodomethane oxidative addition reaction to Rh(I) complexes to form alkyl and acyl product is an essential and relevant reaction in catalytic processes as utilized in industry to produce acetic acid from methanol and carbon monoxide in the Monsanto process [5], [6], [7]. It is known that only one CO ligand in the precursor [Rh(BID)(CO)2] complexes [where BID denote different monocharged bidentate ligands such as cupferrate and 2-oxopyridine N-oxide, etc.] can be substituted by tertiary phosphine ligands (PX3) to form [Rh(BID)(CO)(PX3)] complexes. These complexes have been intensively studied as possible catalysts in model catalytic reactions [8], [9], [10], [11], [12], [13], [14], [15], [16].

The title complex displays a distorted octahedral geometry around the Rh centre indicated by the small bite angle of 79.42(1)° of the five membered chelate ring as well as the C7—Rh—C6, C6—Rh—P1, P1—Rh—I1, P1—Rh—O2 and I1—Rh—C6 angles of 87.24(1), 91.19(8), 96.58(1), 174.32(1) and 171.08(1)°, respectively. The coordination mode in the title complex is similar to the complex reported previously [11], [17]. The Rh—O1, Rh—O2, Rh—P1, Rh—C6 and Rh—I1 bond distances are 2.0494(1), 2.1108(5), 2.2926(6), 2.0930(5) and 2.7448(7) Å, respectively. The lengthening of Rh—O2 compared to Rh—O1 is due to the strong trans influence of the P atom. In the figure the hydrogen atoms have been omitted for clarity.

Acknowledgements

The authors would like to thank the University of the Free State for financial support.

References

1. Sheldrick, G. M.: A short history of SHELX. Acta Crystallogr. A64 (2008) 112–122.10.1107/S0108767307043930Suche in Google Scholar

2. Bruker. SAINT-Plus (Version 7.12) and SADABS (Version 2004/1). Bruker AXS Inc., Madison, WI, USA (2004).Suche in Google Scholar

3. Brandenburg, K.: DIAMOND. Visual Crystal Structure Information System. 3.0c. Crystal Impact, Bonn, Germany (2005).Suche in Google Scholar

4. Dolomanov, O. V.; Bourhis, L. J.; Gildea, R. J.; Howard, J. A. K.; Puschmann, H.: OLEX2: A complete structure solution, refinement and analysis program. J. Appl. Crystallogr. 42 (2009) 339–341.10.1107/S0021889808042726Suche in Google Scholar

5. Elmakki, M. A.; Alexander, O. T.; Venter, G. J. S.; Venter, J. A.: Crystal structure of carbonyl(2-oxopyridin-1(2H-olato-κ2O,O′) (diphenylcyclohexylphosphine-κP)rhodium(I), C24H25NO3PRh. Z. Kristallogr. NCS 232 (2017) 831–833.10.1515/ncrs-2017-0066Suche in Google Scholar

6. Venter, J. A.; Leipoldt, J. G.; Eldik, R. V.: Solvent, temperature, and pressure dependence of oxidative addition of iodomethane to complexes of the type RhI(β-diketone)(CO)(PPh3). Inorg. Chem. 30 (1991) 2207–2209.10.1021/ic00009a046Suche in Google Scholar

7. Hallinan, N.; Hinnenkamp, J.: Rhodium-catalyzed methanol carbonylation: new low water technology. Chem. Ind. 82 (2001) 545.Suche in Google Scholar

8. Basson, S. S.; Leipoldt, J. G.; Roodt, A.; Venter, J. A.: Mechanism for the oxidative addition of iodomethane to carbonyl(N-hydroxy-N-nitrosobenzenaminato-κ2O-O′)-triarylphosphinerhodium(I) complexes and crystal structure of [Rh(cupf)(CO)(CH3)(I)(PPh3)]. Inorg. Chim. Acta 128 (1987) 31–37.10.1016/S0020-1693(00)84691-5Suche in Google Scholar

9. Brink, A.; Roodt, A.; Steyl, G.; Visser, H. G.: Steric vs. electronic anomaly observed from iodomethane oxidative addition to tertiary phosphine modified rhodium(I) acetylacetonato complexes following progressive phenyl replacement by cyclohexyl [PR3 = PPh3, PPh2Cy, PPhCy2, PCy3]. Dalton Trans. 39 (2010) 5572–5578.10.1039/b922083fSuche in Google Scholar

10. Elmakki, M. A.; Koen, R.; Venter, J. A.; Drost, R.: Crystal structure of dicarbonyl(pyridine-2-olate-1-oxido-κ2O,O′)rhodium(I), C7H4NO4Rh. Z. Kristallogr. NCS 231 (2016) 703–705.10.1515/ncrs-2015-0240Suche in Google Scholar

11. Elmakki, M. A.; Koen, R.; Drost, R. M.; Alexander, O. T.; Venter, G. J. S.; Venter, J. A.: Crystal structure of carbonyl(2-oxopyridin-1(2H-olato-κ2O,O′)(triphenylphosphine-κP)rhodium(I), C24H19NO3PRh. Z. Kristallogr. NCS 231 (2016) 781–783.10.1515/ncrs-2015-0266Suche in Google Scholar

12. Roodt, A.; Visser, H. G.; Brink, A.: Structure/reactivity relationships and mechanism from X-ray data and spectroscopic kinetic analysis. Crystallogr. Rev. 17 (2011) 241–280.10.1080/0889311X.2011.593032Suche in Google Scholar

13. Roodt, A.; Otto, S.; Steyl, G.: Structure & solution behaviour of rhodium(I) Vaska-type complexes for correlation of steric & electronic properties of tertiary phosphine ligands. Coord. Chem. Rev. 245 (2003) 121–137.10.1016/S0010-8545(03)00069-9Suche in Google Scholar

14. Warsink, S.; Kotze, P. D. R.; Janse van Rensburg, J. M.; Venter, J. A.; Otto, S.; Botha, E.; Roodt, A.: Kinetic-mechanistic and solid-state study of the oxidative addition and migratory insertion of iodomethane to [Rhodium(S,O-BdiPT or N,O-ox)(CO)(PR1R2R3)] complexes. Eur. J. Inorg. Chem. 32 (2018) 3615–3625.10.1002/ejic.201800293Suche in Google Scholar

15. Conradie, M. M.; van Rooyen, P. H.; Pretorius, C.; Roodt, A.; Conradie, J.: Rhodium-rhodium interactions in [Rh(β-diketonato)(CO)2] complexes. J. Mol. Struct. 1144 (2017) 280–289.10.1016/j.molstruc.2017.04.113Suche in Google Scholar

16. Dobrynin, M. V.; Pretorius, C.; Kama, D. V.; Roodt, A.; Boyarskiy, V. P.; Islamova, R. M.: Rhodium(I)-catalysed cross-linking of polysiloxanes conducted at room temperature. J. Catal. 372 (2019) 193–200.10.1016/j.jcat.2019.03.004Suche in Google Scholar

17. Elmakki, M. A.; Renier, K.; Venter, J. A.; Drost, R.: Crystal structure of dicarbonyl(pyridin-2-olate-1-oxido-κ2O,O′)rhodium(I), C7H4NO4Rh. Z. Kristallogr. NCS 231 (2016) 703–705.10.1515/ncrs-2015-0240Suche in Google Scholar

Received: 2019-08-20
Accepted: 2019-10-08
Published Online: 2019-12-05
Published in Print: 2020-02-25

©2019 Mohammed A. Elmakki et al., published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution 4.0 Public License.

Artikel in diesem Heft

  1. Frontmatter
  2. Synthesis and crystal structure of bis{5-fluorine-2-(((4-(1-(methoxy-imino)ethyl)phenyl) imino)methyl)phenolato-κ2N,O}copper(II), C32H28CuF2N4O4
  3. Redetermination of the crystal structure of N′-(3-ethoxy-2-hydroxybenzylidene)-4-fluorobenzohydrazide monohydrate, C16H17FN2O4
  4. The crystal structure of (E)-N′-(1-(3-chloro-4-fluorophenyl) ethylidene)-2-hydroxybenzohydrazide, C15H12ClFN2O2
  5. Crystal structure of (E)-N-[4-(1H)-imidazolyl phenyl]-(2-methylphenyl)methanimine, C17H15N3
  6. The crystal structure of 1-benzyl-4-(2-(phenylethynyl)phenyl)-1H-1,2,3-triazole, C23H17N3
  7. Crystal structure of catena-poly[{μ2-1,5-bis(diphenylphosphanyl)pentane-κ2P:P′}dichloridocadmium(II)], C29H30CdCl2P2
  8. Crystal structure of methyl (E)-N2-((3-methylquinolin-8-yl)sulfonyl)-Nω-nitro-L-argininate - ethanol (1/1), C19H28N6O7S
  9. The crystal structure of trans-carbonyl-(diphenylcyclohexyl-phosphine-κP)iodidomethyl-(2-oxopyridin-1(2H)-olato-κ2O,O′)rhodium(III), C25H28INO3PRh
  10. Crystal structure of N-(amino(pyrazin-2-yl)methylene)-6-methylpyridin-1-ium-3-carbohydrazonate-κ3O,N,N′)-(dinitrato-κ1O)zinc(II), C12H12N8O7Zn
  11. The crystal structure of dichlorido-(tris(2-benzimidazolylmethyl)amine-κ4N,N′,N′′,N′′′)chromium(III) chloride — methanol (1/3), CrC27H33Cl3N7O3
  12. Crystal structure of catena-poly[aqua(μ4-piperazine-1,4-bis(2-hydroxypropanesulfonato-κ8O,O′:O′,N:N′,O′′:O′′,O′′′))silver(I)], C10H24Ag2N2O10S2
  13. Crystal structure of bis(μ3-oxido)-bis(μ2–2,3,4,5-tetrafluorobenzoato-κ2O:O′)-bis(2,3,4,5-tetrafluorobenzoato-κO)-oktakis(3-chlorobenzyl-κC)tetratin(IV), C84H52Cl8F16O10Sn4
  14. Crystal structure of (E)-1-{4-[(4-fluoro-2-hydroxybenzylidene)amino]phenyl}ethanone O-methyl oxime, C16H15FN2O2
  15. Crystal structure of catena-[(bis(O,O′-diethyl dithiophosphato-S,S′)-μ2-1,2-bis(3-pyridylmethylene)hydrazine-N,N′)zinc(II)], {C20H30N4O4P2S4Zn}n
  16. Crystal structure of methyl 2-(4-(3-iodopyrazolo[1,5-a]pyrimidin-6-yl)phenyl)acetate, C15H12IN3O2
  17. Crystal structure of hexacarbonyl-(μ2-methanoato-k2O:O′)-(μ2–bis(di-p-tolylphosphino)cyclohexylamine-κ2P:P′)dirhenium(I), C42H45NO8P2Re2
  18. The cocrystal structure of 1′-hydroxy-1H,1′H-[5,5′-bitetrazol]-1-olate and 1,10-phenanthrolin-1-ium, C14H10N10O2
  19. The crystal structure of 1-benzyl-2-((4-(tert-butyl)phenyl)ethynyl)pyridin-1-ium bromide,C24H24BrN
  20. Crystal structure of (5,5′-bitetrazole-1,1′-diolate)-bis(1,10-phenanthroline)-copper(II), C26H16CuN12O2
  21. Crystal structure of bis(ammonium) diaqua-tetrakis(4-hydroxybenzoato)-manganese(II) tetrahydrate, [NH4]2[C28H24MnO14] ⋅ 4(H2O)
  22. The crystal structure of 3-chloro-1-hydrazino-2,4,6-trinitrobenzene, C6H4ClN5O6
  23. Crystal structure of catena-[(μ2-pyrazine-κ2N:N′)-bis(O,O′-di-ethyldithiophosphato-κ2S,S′)cadmium(II)], {C12H24CdN2O4P2S4}n
  24. Crystal structure of catena-poly[(μ2-pyrazine-N,N′)-bis(O,O′-di-isopropyldithiophosphato-S,S′)cadmium(II) acetonitrile di-solvate], [C16H32CdN2O4P2S4⋅2(C2H3N)]n
  25. Crystal structure of catena-poly{(μ2-N1,N2-bis[(pyridin-4-yl)methyl]ethanediamide-κ2N:N′)-bis(O,O′-di-isopropyldithiophosphato-κ1S)zinc(II)} — acetonitrile (1/1), C26H42N4O6P2S4Zn⋅C2H3N
  26. Crystal structure of tetraqua-bis(4-(hydroxymethyl)benzoato-κO)cobalt(II), C16H22O10Co
  27. Crystal structure of catena-[(bis(O,O′-diethyl dithiophosphato-S,S′)-μ2-1,2-bis(4-pyridylmethylene)hydrazine-N,N′)cadmium(II)], {C20H30CdN4O4P2S4}n
  28. Crystal structure of catena-poly[(μ2-1,2-bis(3-pyridylmethylene)hydrazine-κ2N:N′)-bis(O,O′-dimethyl dithiophosphato-κ2-S,S′)cadmium(II)], {C16H22CdN4O4P2S4}n
  29. Crystal structure of catena-poly[(bis(O,O′-diethyl dithiophosphato-κ2S,S′)-μ2-1,2-bis(3-pyridylmethylene)hydrazine-κ2N:N′)cadmium(II)], {C20H30CdN4O4P2S4}n
  30. The crystal structure of catena-poly[(E)-2-(((5-((trimethylstannyl)thio)-1,3,4-thiadiazol-2-yl)imino)methyl)phenol], C12H15N3OS2Sn
  31. Crystal structure of dichlorido(N-o-tolyl-1,1-di-p-tolylphosphanamine–κ1P)-(methoxydi-p-tolylphosphane-κ1P)palladium(II), C36H39Cl2NOP2Pd
  32. The crystal structure of the triclinic polymorph of hexameric (trimethylsilyl)methyllithium, C24H66Li6Si6
  33. Crystal structure of bis(hydroxydi(pyridin-2-yl)methanolato-κ3N,N′O)cobalt(III) 7,7,8,8-tetracyanoquinodimethane, C34H22CoN8O4
  34. Synthesis and crystal structure of benzyl 5-oxo-5-phenyl-2-(quinolin-2-yl)pentanoate, C27H23NO3
  35. Crystal structure of 5,5-dimethyl-3-oxocyclohex-1-en-1-yl 4-(2,2-dichloroacetyl)-3,4-dihydro-2 H-benzo[b][1,4]oxazine-7-carboxylate, C19H19Cl2NO5
  36. Crystal structure of dipentyl 2,5-dihydroxycyclohexa-1,4-diene-1,4-dicarboxylate, C18H28O6
  37. The crystal structure of catena-poly[diaqua-(μ4-5-(benzo[d]thiazol-2-yl)benzene-1,3-dicarboxylate-κ4O,O′:O′′,O′′′)-(μ4-5-(benzo[d]thiazol-2-yl)benzene-1,3-dicarboxylate-κ4O,O′:O′′,O′′′)dicadmium(II)], C30H18Cd2N2O10S2
  38. Crystal structure of 2,7-diiodo-1,3,6,8-tetramethyl-bis(difluoroboron)-1,2-bis((1H-pyrrol-2-yl)methylene)hydrazine, C14H14B2F4I2N4
  39. A dinuclear Eu(III) complex in the crystal structure of dodecaaqua-bis(μ2-4-(1H-tetrazol-5-yl)benzoato-κ2O:O′) bis(5-(4-carboxylatophenyl)tetrazol-1-ide) tetrahydrate, C32H50Eu2N16O24
  40. Crystal structure and anti-inflammatory activity of (3E,5E)-3-(2-fluorobenzylidene)-1-((4-fluorophenyl)sulfonyl)-5-(pyridin-3-ylmethylene)piperidin-4-one, C24H18F2N2O3S
  41. Crystal structure and anti-inflammatory activity of (3E,5E)-3-(2-fluorobenzylidene)-1-((4-acetamidophenyl)sulfonyl)-5-(pyridin-3-ylmethylene)piperidin-4-one-methanol-hydrate (2/1/1), C53H50F2N6O10S2
  42. Crystal structure of 4-dimethylamino-pyridin-1-ium uracil-1-acetate, C13H16N4O4
  43. Crystal structure of dimethylammonium 5-fluorouracil-1-acetate, C8H12N3O4F
  44. Crystal structure of bis(N′-((5-(ethoxycarbonyl)-1H-pyrrol-2-yl)methylene)-N-ethylcarbamohydrazonothioato-κ2N,O)nickel(II), C22H30N8O4S2Ni
  45. Crystal structure of chlorido-(η5-pentamethylcyclopentadienyl)-((bis-pyrazol-1-yl)methane-κ2N,N′) rhodium(III) hexafluorophosphate. (C17H23ClN4RhF6P)
  46. The crystal structure of 5-(benzofuran-2-carbonyl)-N-cyclohexyl-5,6-dihydrophenanthridine-6-carboxamide, C29H26N2O3
  47. The crystal structure of 2-oxo-2H-chromen-4-yl acetate, C11H8O4
  48. The crystal structure of 2-nitroisophthalic acid, C8H5NO6
  49. Crystal structure of 3-fluoro-9-methoxy-4b,5,14,15-tetrahydro-6H-isoquinolino [2′,1′:1,6]pyrazino[2,3-b]quinoxaline, C19H17FN4O
  50. Crystal structure of (4-fluorobenzyl-κC)(bis(2-hydroxyethyl) carbamodithioato-κ2S,S′)(2,2′-imino-diethanolato-κ3N,O,O′)tin(IV), C16H25FN2O4S2Sn
  51. Crystal structure and anti-inflammatory activity of (3E,5E)-1-((4-bromophenyl)sulfonyl)-3-(pyridin-4-ylmethylene)-5-(2-(trifluoromethyl)benzylidene)piperidin-4-one, C25H18BrF3N2O3S
  52. Crystal structure and anti-inflammatory activity of (3E,5E)-1-((4-chlorophenyl)sulfonyl)-3-(pyridin-4-ylmethylene)-5-(2-(trifluoromethyl)benzylidene)piperidin-4-one, C25H18ClF3N2O3S
  53. The crystal structure of 3-((1R,2S)-1-methylpyrrolidin-1-ium-2-yl)pyridin-1-ium tetrachloridomanganate(II), C10H16Cl4MnN2
  54. The crystal structure of 3-carboxy-5-methylpyridin-1-ium-2-carboxylate, C8H7NO4
  55. Crystal structure of bis(3-methoxy-N-(1-(pyridin-2-yl)ethylidene)benzohydrazonato κ3O,N,N′)zinc(II), C30H28N6O4Zn
  56. Crystal structure of dichlorido-(4,4′-dichloro-2,2′-bipyridine-κ2N,N′)platinum(II) — acetone (1/1), C13H12Cl4N2PtO
  57. Crystal structure of diethyl 6,12-bis(4-fluorophenyl)-2,10-dimethoxy-3,9-diphenyl-3,9-diazatetracyclo[6.4.0.02,7.04,11]dodecane-1,5-dicarboxylate, C42H42F2N2O6
  58. Synthesis and crystal structure of (1E,3E)-2-hydroxy-5-methylisophthalaldehyde O,O-di(2-((((E)-(2-hydroxynaphthalen-1-yl)methylene)amino)oxy)ethyl) dioxime, C35H32N4O7
  59. The crystal structure of 2-phenyl-4,6-bis(prop-2-yn-1-yloxy)-1,3,5-triazine, C15H11N3O2
  60. Crystal structure of 7-(2-{4-[(4-bromophenyl)methyl]piperazin-1-yl}ethoxy)-2H-chromen-2-one, C22H23BrN2O3
  61. Crystal structure of bis-[N-(3-ethyl-1-pyrazin-2-yl-ethylidene)-3-bromo-benzoic acid-hydrazonato-κ3O,N,N′)]-cadmium(II), C30H28N8O2Br2Cd
  62. Crystal structure of 6-(4-fluorophenyl)-4-methoxy-2H-pyran-2-one, C12H9FO3
  63. Crystal structure of 3-methyl-3-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dien-1-yl)butanoic acid, C14H18O4
  64. The crystal structure of 3-bromo-6-methoxy-2-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, C13H19BBrNO3
  65. The crystal structure of 6-methyl-3,20-dioxo-19-norpregna-4,6-dien-17-yl acetate–2,4-dihydroxybenzoic acid (1/1), C30H36O8
  66. The crystal structure of (5-chloro-2-hydroxy-N-(4-methoxy-2-oxidobenzylidene)benzohydrazonato-κ3N,O,O′)-(pyridine-κ1N)copper(II), C20H16ClCuN3O4
  67. Crystal structure of (E)-2-cyano-N′-(1-(3-ethylpyrazin-2-yl)ethylidene)acetohydrazide, C11H3N5O
  68. Crystal structure of (2,7-dihexyl-9,9-dimethyl-9H-xanthene-4,5-diyl)bis(diphenylphosphane), C51H56OP2
  69. Crystal structure of 5-((bis(pyridin-2-ylmethyl)amino)methyl)quinolin-8-ol, C22H20N4O
  70. Crystal structure of 3-(2-(5-(4-fluorophenyl)-3-(4-methylphenyl)-4,5-dihydro-1H-pyrazol-1-yl)thiazol-4-yl)-2H-chromen-2-one, C28H20FN3O2S
  71. The crystal structure of [(tetra-μ2-2,6-difluorobenzoato-κ2O:O′)-bis-(2,6-difluorobenzoato-κ2O:O′)-bis-(1,10-phenanthroline-κ2N:N′)]dierbium(III) C66H34N4O12F12Er2
  72. Crystal structure of bis(3-chloro-N-(1-(pyrazin-2-yl)ethylidene)benzohydrazonato-k3N,N′,O)nickel(II), C26H20N8O2Cl2Ni
  73. Crystal structure of (E)-3-(3-(5-methyl-1-phenyl-1H-1,2,3-triazol-4-yl)-1-phenyl-1H-pyrazol-4-yl)-1-phenylprop-2-en-1-one, C27H21N5O
  74. Crystal structure of (E)-N′-((4-aminophenyl)sulfonyl)-N,N-dimethylformimidamide, C9H13N3O2S
  75. Crystal structure of η6-p-cymene-iodido-(N-isopropyl-1-(pyridin-2-yl)methanimine-κ2N,N′)ruthenium(II) hexafluorophosphate(V), C19H26IN2F6Ru
  76. Crystal structure of 6-iodo-3-phenyl-2-propylquinazolin-4(3H)-one, C17H15IN2O
  77. Low temperature redetermination of the crystal structure of catena-poly[[tri-4-fluorobenzyltin(IV)]μ2-pyridine-4-carboxylato-κ2N:O], {C27H22F3NO2Sn}n
  78. Crystal structure of bis(2-propyl-1H-benzo[d]imidazol-3-ium) tetrachloridozincate(II), C10H13Cl4N2Zn
  79. The crystal structure of (Z)-3-hydrazono-5-nitroindolin-2-one – dimethyl sulfoxide (1/1), C8H6N4O3
  80. Crystal structure of bis-[N-(1-pyrazin-2-yl-ethylidene)-cyanoacetic acid-hydrazonato-κ3O,N,N′)]-zinc(II), C18H16N10O2Zn
  81. Crystal structure and photochromism of 1-(2,5-dimethyl-3-thienyl)-2-[2-methyl-5-(benzaldoxime)-3-thienyl] perfluorocyclopentene, C23H17F6NOS2
Heruntergeladen am 1.10.2025 von https://www.degruyterbrill.com/document/doi/10.1515/ncrs-2019-0602/html
Button zum nach oben scrollen